Yoana Rabanal-Ruiz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yoana Rabanal-Ruiz has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Juan Ramon Peinado
Molecular Studies Applied to Health Sciences Group (EMAS), Department of Medical Sciences, Faculty of Medicine of Ciudad Real, Institute of Biomedicine (IB-UCLM), University of Castilla-La Mancha, Paseo de Moledores s/n, 13071 Ciudad Real, Spain
8 shared publications - Maria M. Malagon
CIBER de la Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
8 shared publications - Javier Frontiñán-Rubio
Oxidative Stress and Neurodegeneration Group, Universidad de Castilla-La Mancha, Ciudad Real, Spain
7 shared publications - Viktor I. Korolchuk
Newcastle University Bioscience Institute
7 shared publications - Alberto Diaz-Ruiz
Laboratory of Cellular and Molecular Gerontology, Precision Nutrition and Aging Program, Institute IMDEA Food (CEI UAM+CSIC), Madrid, Spain
6 shared publications - Mario Durán-Prado
Oxidative Stress and Neurodegeneration Group, Medical Sciences Department, Medical School, UCLM, Ciudad Real, Spain
6 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9506
Blood–CSF MiRNA Signatures in Alzheimer’s Disease Reveal Novel Biomarker Candidates: A Systematic Review
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline. MicroRNAs (miRNAs) have emerged as promising regulators of AD-related pathways and potential minimally invasive biomarkers. However, existing meta-analyses have yielded inconsistent results, and whether miRNA signatures are conserved across biological fluids remains unclear. The present work aimed to systematically review studies performing miRNA discovery or multi-candidate profiling in blood and CSF during the last 15 years, in order to identify miRNAs showing significant and consistent differential expression across independent studies. By systematically comparing the direction and consistency of miRNA dysregulation across independent studies and biological sources, we identified 80 miRNAs consistently dysregulated in both blood and CSF, revealing a reproducible cross-fluid signature of AD-associated molecular alterations. Notably, miR-451a and miR-16-5p emerged among the most consistently dysregulated miRNAs across fluids. In contrast, several miRNAs displayed divergent or compartment-specific patterns, highlighting that blood and CSF may capture distinct aspects of AD-related molecular changes. Among these, miR-484, miR-3200-3p and miR-598 were identified as novel CSF candidates, while miR-20a-5p, miR-363-3p and miR-5006-3p represented novel blood-specific candidates. Furthermore, a substantial proportion of detected miRNAs was associated with extracellular vesicle/exosomal fractions, supporting their potential stability and biological relevance. Overall, our findings demonstrate that AD-associated miRNA dysregulation comprises both conserved and biofluid-specific signatures. From a clinical perspective, the current evidence primarily supports further evaluation of miRNAs as diagnostic/discriminative biomarkers rather than validated tools for early detection, disease monitoring, or prognosis. Their clinical translation remains limited by biofluid and methodological heterogeneity and requires harmonized cross-cohort and longitudinal validation.
- 24 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9506
Open AccessBlood–CSF MiRNA Signatures in Alzheimer’s Disease Reveal Novel Biomarker Candidates: A Systematic Review
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline. MicroRNAs (miRNAs) have emerged as promising regulators of AD-related pathways and potential minimally invasive biomarkers. However, existing meta-analyses have yielded inconsistent results, and whether miRNA signatures are conserved across biological fluids remains unclear. The present work aimed to systematically review studies performing miRNA discovery or multi-candidate profiling in blood and CSF during the last 15 years, in order to identify miRNAs showing significant and consistent differential expression across independent studies. By systematically comparing the direction and consistency of miRNA dysregulation across independent studies and biological sources, we identified 80 miRNAs consistently dysregulated in both blood and CSF, revealing a reproducible cross-fluid signature of AD-associated molecular alterations. Notably, miR-451a and miR-16-5p emerged among the most consistently dysregulated miRNAs across fluids. In contrast, several miRNAs displayed divergent or compartment-specific patterns, highlighting that blood and CSF may capture distinct aspects of AD-related molecular changes. Among these, miR-484, miR-3200-3p and miR-598 were identified as novel CSF candidates, while miR-20a-5p, miR-363-3p and miR-5006-3p represented novel blood-specific candidates. Furthermore, a substantial proportion of detected miRNAs was associated with extracellular vesicle/exosomal fractions, supporting their potential stability and biological relevance. Overall, our findings demonstrate that AD-associated miRNA dysregulation comprises both conserved and biofluid-specific signatures. From a clinical perspective, the current evidence primarily supports further evaluation of miRNAs as diagnostic/discriminative biomarkers rather than validated tools for early detection, disease monitoring, or prognosis. Their clinical translation remains limited by biofluid and methodological heterogeneity and requires harmonized cross-cohort and longitudinal validation.
- Open Access
Exploratory spatial peptidomic profiling during incubation of drug seeking following cocaine plus alcohol self-administration in young adult rats
Background: Concurrent cocaine and alcohol use is one of the most prevalent forms of polysubstance consumption and is associated with poorer clinical outcomes than cocaine use alone. However, the regional molecular adaptations induced by combined exposure remain poorly understood. Here, we used matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) to characterize peptide/protein alterations in addiction-related brain regions following cocaine and cocaine–alcohol self-administration. Methods: Young adult male and female Wistar rats underwent intravenous self-administration of saline, cocaine (1 mg/kg/infusion) or cocaine plus ethanol (1 mg/kg cocaine and 133 mg/kg ethanol per infusion), followed by extinction of drug-seeking behaviour. Coronal brain sections containing the anterior cingulate cortex (ACC) and ventral hippocampus (vHPC) were analysed by MALDI-IMS. Differential molecular features were identified using an exploratory statistical approach (FDR q < 0.20) and subsequently subjected to MS/MS analysis. Results: The ACC exhibited a substantially greater number of treatment-associated molecular alterations than the vHPC, suggesting a higher regional susceptibility to cocaine-induced molecular remodelling. Several molecular features were shared between the cocaine and cocaine–alcohol groups, indicating persistent cocaine-driven neuroadaptations. In contrast, additional signals were selectively associated with combined cocaine–alcohol exposure, while others present after cocaine alone were absent following alcohol co-exposure, supporting a modulatory effect of alcohol on specific cocaine-induced molecular responses. Overall, combined exposure generated a distinct regional molecular profile rather than simply reproducing the effects of cocaine alone. Conclusions: This exploratory study demonstrates that MALDI-IMS enables the identification of region-specific peptide/protein alterations associated with cocaine and cocaine–alcohol exposure while preserving their spatial distribution within the brain. These findings highlight the ACC as a particularly responsive region and provide a framework for future studies aimed at validating molecular pathways involved in cocaine–alcohol polysubstance use.
Open AccessExploratory spatial peptidomic profiling during incubation of drug seeking following cocaine plus alcohol self-administration in young adult rats
Background: Concurrent cocaine and alcohol use is one of the most prevalent forms of polysubstance consumption and is associated with poorer clinical outcomes than cocaine use alone. However, the regional molecular adaptations induced by combined exposure remain poorly understood. Here, we used matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) to characterize peptide/protein alterations in addiction-related brain regions following cocaine and cocaine–alcohol self-administration. Methods: Young adult male and female Wistar rats underwent intravenous self-administration of saline, cocaine (1 mg/kg/infusion) or cocaine plus ethanol (1 mg/kg cocaine and 133 mg/kg ethanol per infusion), followed by extinction of drug-seeking behaviour. Coronal brain sections containing the anterior cingulate cortex (ACC) and ventral hippocampus (vHPC) were analysed by MALDI-IMS. Differential molecular features were identified using an exploratory statistical approach (FDR q < 0.20) and subsequently subjected to MS/MS analysis. Results: The ACC exhibited a substantially greater number of treatment-associated molecular alterations than the vHPC, suggesting a higher regional susceptibility to cocaine-induced molecular remodelling. Several molecular features were shared between the cocaine and cocaine–alcohol groups, indicating persistent cocaine-driven neuroadaptations. In contrast, additional signals were selectively associated with combined cocaine–alcohol exposure, while others present after cocaine alone were absent following alcohol co-exposure, supporting a modulatory effect of alcohol on specific cocaine-induced molecular responses. Overall, combined exposure generated a distinct regional molecular profile rather than simply reproducing the effects of cocaine alone. Conclusions: This exploratory study demonstrates that MALDI-IMS enables the identification of region-specific peptide/protein alterations associated with cocaine and cocaine–alcohol exposure while preserving their spatial distribution within the brain. These findings highlight the ACC as a particularly responsive region and provide a framework for future studies aimed at validating molecular pathways involved in cocaine–alcohol polysubstance use.
- Open Access
AMPK senses cellular levels of nicotinamide adenine dinucleotide
The electron shuttle and coenzyme nicotinamide adenine nucleotide (NAD) is essential for cellular metabolism and homeostasis. NAD levels significantly fluctuate in cells, whilst ageing and age-related diseases are associated with depletion of this metabolite. However, how NAD changes are monitored by nutrient/energy sensing signalling pathways remains poorly understood. We found that at physiological concentrations NAD controls the activity of the AMP-activated protein kinase (AMPK) in vitro and in human cells. Mechanistically, NAD binds gamma subunit of AMPK, and mutagenesis of the putative binding site renders the holoenzyme insensitive to NAD inhibition. Hyperactivation of AMPK in response to NAD depletion suppresses metabolic pathways including mammalian Target of Rapamycin Complex I (mTORC1) and autophagy. These results demonstrate that in addition to monitoring cellular energy levels AMPK functions as a NAD sensor, providing novel insight into how cells and tissues detect and respond to metabolic fluctuations with implications for stress resistance and ageing.
Open AccessAMPK senses cellular levels of nicotinamide adenine dinucleotide
The electron shuttle and coenzyme nicotinamide adenine nucleotide (NAD) is essential for cellular metabolism and homeostasis. NAD levels significantly fluctuate in cells, whilst ageing and age-related diseases are associated with depletion of this metabolite. However, how NAD changes are monitored by nutrient/energy sensing signalling pathways remains poorly understood. We found that at physiological concentrations NAD controls the activity of the AMP-activated protein kinase (AMPK) in vitro and in human cells. Mechanistically, NAD binds gamma subunit of AMPK, and mutagenesis of the putative binding site renders the holoenzyme insensitive to NAD inhibition. Hyperactivation of AMPK in response to NAD depletion suppresses metabolic pathways including mammalian Target of Rapamycin Complex I (mTORC1) and autophagy. These results demonstrate that in addition to monitoring cellular energy levels AMPK functions as a NAD sensor, providing novel insight into how cells and tissues detect and respond to metabolic fluctuations with implications for stress resistance and ageing.
- Open Access
Ambient Levels of Carbonyl Compounds and Ozone in a Golf Course in Ciudad Real, Spain: A ProtoPRED QSAR (Eco) Toxicity Evaluation
It is well known that carbonyl compounds play an important role in air pollution and the formation of secondary pollutants, such as peroxyacetyl nitrates (PAN). Additionally, airborne carbonyls have been described as cytotoxic, mutagenic and carcinogenic. In this research, several carbonyl compounds, including aldehydes and ketones, as well as ozone, were monitored during a campaign conducted in July and September-October 2023 at Golf Ciudad Real, a golf course located in a non-industrial area of a south-central province in Spain. Extraction and analysis were carried out following procedures outlined by Radiello®. Analyses were performed using HPLC-DAD and UV-Visible spectrophotometry. Ozone shows seasonal variation (temperature-dependent) concentrations displaying lower values in September/October. Among all the identified carbonyls, butanal was the most abundant, accounting for 40% of the total concentration. The C1/C2 and C2/C3 ratios were also calculated to provide information about the main emissions sources of the analyzed carbonyl compounds, indicating that mainly anthropogenic sources contribute to air quality in the area. The data were further supported by Quantitative Structure-Activity Relationship (QSAR) models using the ProtoPRED online server, which employs in silico methods based on European Chemicals Agency (ECHA) regulations to assess the (eco)toxicity of the measured carbonyl compounds.
Open AccessAmbient Levels of Carbonyl Compounds and Ozone in a Golf Course in Ciudad Real, Spain: A ProtoPRED QSAR (Eco) Toxicity Evaluation
It is well known that carbonyl compounds play an important role in air pollution and the formation of secondary pollutants, such as peroxyacetyl nitrates (PAN). Additionally, airborne carbonyls have been described as cytotoxic, mutagenic and carcinogenic. In this research, several carbonyl compounds, including aldehydes and ketones, as well as ozone, were monitored during a campaign conducted in July and September-October 2023 at Golf Ciudad Real, a golf course located in a non-industrial area of a south-central province in Spain. Extraction and analysis were carried out following procedures outlined by Radiello®. Analyses were performed using HPLC-DAD and UV-Visible spectrophotometry. Ozone shows seasonal variation (temperature-dependent) concentrations displaying lower values in September/October. Among all the identified carbonyls, butanal was the most abundant, accounting for 40% of the total concentration. The C1/C2 and C2/C3 ratios were also calculated to provide information about the main emissions sources of the analyzed carbonyl compounds, indicating that mainly anthropogenic sources contribute to air quality in the area. The data were further supported by Quantitative Structure-Activity Relationship (QSAR) models using the ProtoPRED online server, which employs in silico methods based on European Chemicals Agency (ECHA) regulations to assess the (eco)toxicity of the measured carbonyl compounds.
- Open Access
- 20 November 2023
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15, 1331799
Editorial: Present and future of biological fluid biomarkers in dementia
Editorial: Present and future of biological fluid biomarkers in dementia
- 20 November 2023
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15, 1331799
Open AccessEditorial: Present and future of biological fluid biomarkers in dementia
Editorial: Present and future of biological fluid biomarkers in dementia
- Open Access
- 4 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S406
PROTECTIVE EFFECT OF COENZYME Q10 AGAINST AMYLOID PATHOLOGY IN ALZHEIMER'S DISEASE. A JOURNEY FROM CELLULAR MODELS TO THE USE OF MALDI-MSI IN 3XTG-AD MICE
- 4 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S406
Open AccessPROTECTIVE EFFECT OF COENZYME Q10 AGAINST AMYLOID PATHOLOGY IN ALZHEIMER'S DISEASE. A JOURNEY FROM CELLULAR MODELS TO THE USE OF MALDI-MSI IN 3XTG-AD MICE
- Open Access
- 14 September 2023
- Published by Springer Nature in Research Square
Dissimilar accumulation of human β-amyloid and tau from enriched extracts in neuronal and endothelial cells
BACKGROUND: While Aβ and Tau cellular distribution has been largely studied, the comparative internalization and subcellular accumulation of Tau and Aβ isolated from human brain extracts in endothelial and neuronal cells has not yet been unveiled. We have previously demonstrated that controlled enrichment of Aβ from human brain extracts constitutes a valuable tool to monitor cellular internalizationin vitroandin vivo. METHODS: Herein, we establish an alternative method to strongly enrich Aβ and Tau aggregates from human AD brains, which has allowed us to study and compare the cellular internalization, distribution and toxicity of both proteins within brain barrier endothelial (bEnd.3) and neuronal (Neuro2A) cells. RESULTS: Our findings demonstrate the suitability of human enriched brain extracts to monitor the intracellular distribution of human Aβ and Tau, which, once internalized, show dissimilar sorting to different organelles within the cell and differential toxicity, exhibiting higher toxic effects on neuronal cells than on endothelial cells. While tau is strongly concentrated preferentially in mitochondria, Aβ is distributed predominantly within the endolysosomal system in endothelial cells, whereas the endoplasmic reticulum was its preferential location in neurons. Altogether, our findings display a picture of the cellular events that might occur in AD. CONCLUSIONS: Monitoring the transit of internalized human Aβ and tau comparatively uncovers, for the first time, differences regarding their accumulation within the endolysosomal system, endoplasmic reticulum, mitochondria and autophagosomes, which might explain their differential cell-dependent toxicity. Overall, this study constitutes the first approach aimed at identifying the mechanism used by Aβ, tau and potential cofactors to exert cellular toxicity. Future studies must address the consequences of the accumulation of these proteins in different organelles and their relation to cell-to-cell transmission proposed for both proteins as part of the prion-like hypothesis of AD.
- 14 September 2023
- Published by Springer Nature in Research Square
Open AccessDissimilar accumulation of human β-amyloid and tau from enriched extracts in neuronal and endothelial cells
BACKGROUND: While Aβ and Tau cellular distribution has been largely studied, the comparative internalization and subcellular accumulation of Tau and Aβ isolated from human brain extracts in endothelial and neuronal cells has not yet been unveiled. We have previously demonstrated that controlled enrichment of Aβ from human brain extracts constitutes a valuable tool to monitor cellular internalizationin vitroandin vivo. METHODS: Herein, we establish an alternative method to strongly enrich Aβ and Tau aggregates from human AD brains, which has allowed us to study and compare the cellular internalization, distribution and toxicity of both proteins within brain barrier endothelial (bEnd.3) and neuronal (Neuro2A) cells. RESULTS: Our findings demonstrate the suitability of human enriched brain extracts to monitor the intracellular distribution of human Aβ and Tau, which, once internalized, show dissimilar sorting to different organelles within the cell and differential toxicity, exhibiting higher toxic effects on neuronal cells than on endothelial cells. While tau is strongly concentrated preferentially in mitochondria, Aβ is distributed predominantly within the endolysosomal system in endothelial cells, whereas the endoplasmic reticulum was its preferential location in neurons. Altogether, our findings display a picture of the cellular events that might occur in AD. CONCLUSIONS: Monitoring the transit of internalized human Aβ and tau comparatively uncovers, for the first time, differences regarding their accumulation within the endolysosomal system, endoplasmic reticulum, mitochondria and autophagosomes, which might explain their differential cell-dependent toxicity. Overall, this study constitutes the first approach aimed at identifying the mechanism used by Aβ, tau and potential cofactors to exert cellular toxicity. Future studies must address the consequences of the accumulation of these proteins in different organelles and their relation to cell-to-cell transmission proposed for both proteins as part of the prion-like hypothesis of AD.
- Open Access
- 19 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 747
Spatial and Temporal Protein Modules Signatures Associated with Alzheimer Disease in 3xTg-AD Mice Are Restored by Early Ubiquinol Supplementation
Despite its robust proteopathic nature, the spatiotemporal signature of disrupted protein modules in sporadic Alzheimer’s disease (AD) brains remains poorly understood. This considered oxidative stress contributes to AD progression and early intervention with coenzyme Q10 or its reduced form, ubiquinol, delays the progression of the disease. Using MALDI–MSI and functional bioinformatic analysis, we have developed a protocol to express how deregulated protein modules arise from hippocampus and cortex in the AD mice model 3xTG-AD in an age-dependent manner. This strategy allowed us to identify which modules can be efficiently restored to a non-pathological condition by early intervention with ubiquinol. Indeed, an early deregulation of proteostasis-related protein modules, oxidative stress and metabolism has been observed in the hippocampus of 6-month mice (early AD) and the mirrored in cortical regions of 12-month mice (middle/late AD). This observation has been validated by IHC using mouse and human brain sections, suggesting that these protein modules are also affected in humans. The emergence of disrupted protein modules with AD signature can be prevented by early dietary intervention with ubiquinol in the 3xTG-AD mice model.
- 19 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 747
Open AccessSpatial and Temporal Protein Modules Signatures Associated with Alzheimer Disease in 3xTg-AD Mice Are Restored by Early Ubiquinol Supplementation
Despite its robust proteopathic nature, the spatiotemporal signature of disrupted protein modules in sporadic Alzheimer’s disease (AD) brains remains poorly understood. This considered oxidative stress contributes to AD progression and early intervention with coenzyme Q10 or its reduced form, ubiquinol, delays the progression of the disease. Using MALDI–MSI and functional bioinformatic analysis, we have developed a protocol to express how deregulated protein modules arise from hippocampus and cortex in the AD mice model 3xTG-AD in an age-dependent manner. This strategy allowed us to identify which modules can be efficiently restored to a non-pathological condition by early intervention with ubiquinol. Indeed, an early deregulation of proteostasis-related protein modules, oxidative stress and metabolism has been observed in the hippocampus of 6-month mice (early AD) and the mirrored in cortical regions of 12-month mice (middle/late AD). This observation has been validated by IHC using mouse and human brain sections, suggesting that these protein modules are also affected in humans. The emergence of disrupted protein modules with AD signature can be prevented by early dietary intervention with ubiquinol in the 3xTG-AD mice model.
- Open Access
- 20 August 2022
- Published by Springer Nature in Clinical Epigenetics
- Vol. 14 (1) , 1-14
Genomic targets and selective inhibition of DNA methyltransferase isoforms
Background: DNA methylation in the human genome is established and maintained by DNA methyltransferases (DNMTs). DNMT isoforms show differential expression by cell lineage and during development, but much remains to be elucidated about their shared and unique genomic targets. Results: We examined changes in the epigenome following overexpression of 13 DNMT isoforms in HEK293T cells. We observed increased methylation (Δβ > 0.2) at 43,405 CpG sites, with expression of DNMT3A2, DNMTΔ3B4 and DNMTΔ3B2 associated with the greatest impact. De novo methylation occurred primarily within open sea regions and at loci with intermediate methylation levels (β: 0.2–0.6). 53% of differentially methylated loci showed specificity towards a single DNMT subfamily, primarily DNMTΔ3B and DNMT3A and 39% towards a single isoform. These loci were significantly enriched for pathways related to neuronal development (DNMTΔ3B4), calcium homeostasis (DNMTΔ3B3) and ion transport (DNMT3L). Repetitive elements did not display differential sensitivity to overexpressed DNMTs, but hypermethylation of Alu elements was associated with their evolutionary age following overexpression of DNMT3A2, DNMT3B1, DNMT3B2 and DNMT3L. Differential methylation (Δβ > 0.1) was observed at 121 of the 353 loci associated with the Horvath ‘epigenetic clock’ model of ageing, with 51 showing isoform specificity, and was associated with reduction of epigenetic age by 5–15 years following overexpression of seven isoforms. Finally, we demonstrate the potential for dietary constituents to modify epigenetic marks through isoform-specific inhibition of methylation activity. Conclusions: Our results provide insight into regions of the genome methylated uniquely by specific DNMT isoforms and demonstrate the potential for dietary intervention to modify the epigenome.
- 20 August 2022
- Published by Springer Nature in Clinical Epigenetics
- Vol. 14 (1) , 1-14
Open AccessGenomic targets and selective inhibition of DNA methyltransferase isoforms
Background: DNA methylation in the human genome is established and maintained by DNA methyltransferases (DNMTs). DNMT isoforms show differential expression by cell lineage and during development, but much remains to be elucidated about their shared and unique genomic targets. Results: We examined changes in the epigenome following overexpression of 13 DNMT isoforms in HEK293T cells. We observed increased methylation (Δβ > 0.2) at 43,405 CpG sites, with expression of DNMT3A2, DNMTΔ3B4 and DNMTΔ3B2 associated with the greatest impact. De novo methylation occurred primarily within open sea regions and at loci with intermediate methylation levels (β: 0.2–0.6). 53% of differentially methylated loci showed specificity towards a single DNMT subfamily, primarily DNMTΔ3B and DNMT3A and 39% towards a single isoform. These loci were significantly enriched for pathways related to neuronal development (DNMTΔ3B4), calcium homeostasis (DNMTΔ3B3) and ion transport (DNMT3L). Repetitive elements did not display differential sensitivity to overexpressed DNMTs, but hypermethylation of Alu elements was associated with their evolutionary age following overexpression of DNMT3A2, DNMT3B1, DNMT3B2 and DNMT3L. Differential methylation (Δβ > 0.1) was observed at 121 of the 353 loci associated with the Horvath ‘epigenetic clock’ model of ageing, with 51 showing isoform specificity, and was associated with reduction of epigenetic age by 5–15 years following overexpression of seven isoforms. Finally, we demonstrate the potential for dietary constituents to modify epigenetic marks through isoform-specific inhibition of methylation activity. Conclusions: Our results provide insight into regions of the genome methylated uniquely by specific DNMT isoforms and demonstrate the potential for dietary intervention to modify the epigenome.
- Open Access
- 13 November 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (11) , 1806
The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
Vascular brain pathology constitutes a common feature in neurodegenerative diseases that could underlie their development. Indeed, vascular dysfunction acts synergistically with neurodegenerative changes to exacerbate the cognitive impairment found in Alzheimer’s disease. Different injuries such as hypertension, high glucose, atherosclerosis associated with oxidized low-density lipoprotein or inflammation induce NADPH oxidase activation, overproduction of reactive oxygen species, and apoptosis in endothelial cells. Since it has been shown that pretreatment of cultured endothelial cells with the lipophilic antioxidant coenzyme Q10 (CoQ10) displays a protective effect against the deleterious injuries caused by different agents, this study explores the cytoprotective role of different CoQs homologues against Aβ25–35-induced damage and demonstrates that only pretreatment with CoQ10 protects endothelial brain cells from Aβ25–35-induced damage. Herein, we show that CoQ10 constitutes the most effective ubiquinone in preventing NADPH oxidase activity and reducing both reactive oxygen species generation and the increase in free cytosolic Ca2+ induced by Aβ25–35, ultimately preventing apoptosis and necrosis. The specific cytoprotective effect of CoQ with a side chain of 10 isoprenoid units could be explained by the fact that CoQ10 is the only ubiquinone that significantly reduces the entry of Aβ25–35 into the mitochondria.
- 13 November 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (11) , 1806
Open AccessThe Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
Vascular brain pathology constitutes a common feature in neurodegenerative diseases that could underlie their development. Indeed, vascular dysfunction acts synergistically with neurodegenerative changes to exacerbate the cognitive impairment found in Alzheimer’s disease. Different injuries such as hypertension, high glucose, atherosclerosis associated with oxidized low-density lipoprotein or inflammation induce NADPH oxidase activation, overproduction of reactive oxygen species, and apoptosis in endothelial cells. Since it has been shown that pretreatment of cultured endothelial cells with the lipophilic antioxidant coenzyme Q10 (CoQ10) displays a protective effect against the deleterious injuries caused by different agents, this study explores the cytoprotective role of different CoQs homologues against Aβ25–35-induced damage and demonstrates that only pretreatment with CoQ10 protects endothelial brain cells from Aβ25–35-induced damage. Herein, we show that CoQ10 constitutes the most effective ubiquinone in preventing NADPH oxidase activity and reducing both reactive oxygen species generation and the increase in free cytosolic Ca2+ induced by Aβ25–35, ultimately preventing apoptosis and necrosis. The specific cytoprotective effect of CoQ with a side chain of 10 isoprenoid units could be explained by the fact that CoQ10 is the only ubiquinone that significantly reduces the entry of Aβ25–35 into the mitochondria.